A phase II trial of vinorelbine and intensive temozolomide for patients with recurrent or progressive brain metastases
✍ Scribed by Fabio M. Iwamoto; Antonio M. Omuro; Jeffrey J. Raizer; Craig P. Nolan; Adília Hormigo; Andrew B. Lassman; Igor T. Gavrilovic; Lauren E. Abrey
- Publisher
- Springer US
- Year
- 2007
- Tongue
- English
- Weight
- 163 KB
- Volume
- 87
- Category
- Article
- ISSN
- 0167-594X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Objective. We assessed the response rate and the toxicity of cisplatin plus vinorelbine in patients with this condition. ## Patients and Method. Forty‐two patients were included. Therapy consisted of cisplatin, 100 mg/m^2^ on day 1, and vinorelbine, 25 mg/m^2^ on days 1 and 8, giv
## Abstract ## BACKGROUND The objective of this study was to assess the efficacy and toxicity of the imidazotetrazine derivative temozolomide for patients with unresectable or metastatic soft tissue sarcoma. ## METHODS Twenty‐five of 26 patients were eligible and assessable for toxicity and resp